Please turn JavaScript on
Drug Development and Delivery icon

Drug Development and Delivery

Want to stay in touch with the latest updates from Drug Development and Delivery? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Drug Development & Delivery - The Latest Methods in Drug Development

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.15 / day

Message History

Wilmington, North Carolina,– Alcami Corporation, a leading contract development and manufacturing organization (CDMO), today announced a series of strategic and operational investments at its Tennessee facility, which was recently added to the company’s network through its acquisition of Tjoapack.

Looking to strengthen operational consistency and quali...


Read full story

Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance MabionCD20 for pot...


Read full story

LONDON, United Kingdom —  LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise therapeutic antibodies, today announced a multi-year research collaboration, option and licensing agreement with LG Chem. The collaboration aims to identify next-generation multispecific antibodies design...


Read full story

Delft, The Netherlands,  InnoGI Technologies announced the launch of TIM Cell, a novel apparent permeability service designed specifically to work with TIM intestinal fluids (TIF). By combining biorelevant gastro-intestinal simulation with dynamic intestinal permeability assessment, TIM Cell helps bridge the gap between bioaccessibility and absorption in oral drug develo...


Read full story

Auburn, Alabama, Aptar Active Material Science, part of AptarGroup, Inc. and a global leader in active material science solutions, has announced a significant intellectual property milestone in its nitrosamine risk mitigation platform. The company’s foundational U.S. patent application for its N-Sorb technology has been approved by the United...


Read full story